Recent Articles from GlobeNewswire

Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
Ad hoc announcement pursuant to Art. 53 LR
Shell fourth quarter 2025 update note
The following is an update to the fourth quarter 2025 outlook and gives an overview of our current expectations for the fourth quarter. Outlooks presented may vary from the actual fourth quarter 2025 results and are subject to finalisation of those results, which are scheduled to be published on February 5, 2026. Unless otherwise indicated, all outlook statements exclude identified items. 
By Shell plc · Via GlobeNewswire · January 8, 2026
Eleva appoints Erich Rajkovic as new Chief Business Officer
Freiburg im Breisgau, Germany – January 8, 2026 – Eleva, a pioneer in discovering and developing previously inaccessible biologics, today announced the appointment of Dr. Erich Rajkovic, MBA, as Chief Business Officer. Erich Rajkovic joined Eleva from Affimed, Mannheim/Germany, where he played a key role in originating, negotiating and closing several strategic partnerships with leading pharma and biotechnology companies, as well as academic institutions. At Eleva, he will lead the continued strategic expansion of the company’s pipeline and partnering activities across proprietary programs and external collaborations, supporting the company’s next phase of growth.
By eleva GmbH · Via GlobeNewswire · January 8, 2026
Tensive reports positive pivotal trial top-line results showing REGENERA™ bioresorbable device may transform breast reconstruction
Milan, Italy – January 8, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™/SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, today announced top-line results from a pivotal trial evaluating the REGENERA™ implant in patients undergoing lumpectomy to treat malignant lesions.
By Tensive · Via GlobeNewswire · January 8, 2026
Basilea provides portfolio update and outlook
Allschwil, Switzerland, January 08, 2026
Pharming Group reports preliminary 2025 revenues and announces Investor Day
Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced its preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026, at 10:00 am EST (16:00 CET).
By Pharming Group N.V. · Via GlobeNewswire · January 8, 2026
Sodexo Q1 Fiscal 2026 revenues in line with expectations
Issy-les-Moulineaux, January 8, 2026 (7am)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)
By Sodexo SA · Via GlobeNewswire · January 8, 2026
authID and TurboCheck Selected by Global Workforce Solutions Provider to Address the Surge of Employment Identity Fraud
New global customer win underscores authID’s growing leadership in workforce verification and the urgent need for deepfake-resistant identity proofing in hiring
By authID Inc. · Via GlobeNewswire · January 8, 2026
Sprouts Farmers Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Sprouts Farmers Market, Inc. - SFM
NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sprouts Farmers Market, Inc. (“Sprouts” or the “Company”) (NasdaqGS: SFM), if they purchased or otherwise acquired the Company’s securities between June 4, 2025 and October 29, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
DeFi Technologies Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against DeFi Technologies Inc. - DEFT
NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against DeFi Technologies Inc. (“DeFi” or the “Company”) (NasdaqCM: DEFT), if they purchased or otherwise acquired the Company’s securities between May 12, 2025 and November 14, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
OBOOK Holdings Inc. (OWLS) to Adopt x402 Standard to Unlock AI Agent Revenue for Global Merchants
Leveraging its global regulatory footprint, OwlTing aims to provide merchants the ability to accept payments from the next generation of AI buyers
By OwlTing Group · Via GlobeNewswire · January 7, 2026
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public offering of 6,875,000 shares of its common stock and pre-funded warrants to purchase 1,250,078 shares of common stock. The shares of common stock are being sold to the public at a price of $16.00 per share and the pre-funded warrants are being sold at a price of $15.999 per pre-funded warrant, which represents the per share price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. The gross proceeds to Phathom from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $130 million. In addition, Phathom has granted the underwriters a 30-day option to purchase up to an additional 1,218,761 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about January 9, 2026, subject to satisfaction of customary closing conditions.
By Phathom Pharmaceuticals · Via GlobeNewswire · January 7, 2026
F5 Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against F5, Inc. - FFIV
NEW ORLEANS, La., Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Washington.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Alexandria Real Estate Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Alexandria Real Estate Equities, Inc. - ARE
NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE), if they purchased or otherwise acquired the Company’s securities between January 27, 2025 to October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Klarna Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Klarna Group plc - KLAR
NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Klarna Group plc (NYSE: KLAR), if they purchased the Company’s securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna’s September 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Eastern District of New York.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Bitdeer Technologies Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Bitdeer Technologies Group - BTDR
NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Bitdeer Technologies Group (“Bitdeer” or the "Company") (NasdaqCM: BTDR), if they purchased or otherwise acquired the Company’s securities between June 6, 2024 and November 10, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Jayud Global Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Jayud Global Logistics Limited - JYD
NEW ORLEANS, La., Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 19, 2026 to file lead plaintiff applications in a securities class action lawsuit against Jayud Global Logistics Limited (“Jayud” or the “Company”) (NasdaqCM: JYD), if they purchased or otherwise acquired the Company’s securities between April 21, 2023 and April 30, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Integer Holdings Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Integer Holdings Corporation - ITGR
NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Stride Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Stride, Inc. - LRN
NEW ORLEANS and LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 12, 2026 to file lead plaintiff applications in a securities class action lawsuit against Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN), if they purchased or otherwise acquired the Company’s securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of Virginia.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Coupang Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Coupang, Inc. - CPNG
NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against Coupang, Inc. (NYSE: CPNG), if they purchased or otherwise acquired the Company’s securities between May 7, 2025 and December 16, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Courts for the Northern District of California and Western District of Washington.
By SkyMedia, LLC · Via GlobeNewswire · January 7, 2026
Minim Martap Development Update
Highlights
By Canyon Resources Limited · Via GlobeNewswire · January 7, 2026
Statement from the Academy of Nutrition and Dietetics on the Release of the Dietary Guidelines for Americans, 2025–2030
Chicago, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics acknowledges the release of the Dietary Guidelines for Americans, 2025–2030 (DGAs). While many recommendations align with longstanding nutrition science, other elements raise concerns that could be detrimental to public health.
Jefferson Capital Announces Pricing of Secondary Public Offering and Concurrent Share Repurchase
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. (Nasdaq: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced the pricing of the underwritten public offering of 10,000,000 shares of common stock by certain of its existing stockholders at a price to the public of $20.50 per share. In addition, the underwriters of the offering have a 30-day option to purchase from the selling stockholders up to 1,500,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The selling stockholders will receive all of the net proceeds from this offering. As part of the secondary offering, Jefferson Capital has agreed to concurrently purchase 3,000,000 shares of its common stock from the underwriters at a per-share purchase price equal to the price payable by the underwriters to the selling stockholders in the offering. The offering and the concurrent share repurchase are expected to close on January 9, 2026, subject to customary closing conditions.
By Jefferson Capital · Via GlobeNewswire · January 7, 2026
Aqueous Announces National “Celebrating the Wines of Hungary” Campaign as U.S. Consumer Interest in Heritage-Driven Wine Categories Grows
Dallas, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Aqueous Spirits, a U.S.-based importer specializing in premium Hungarian wines, today announced the launch of its national “Celebrating the Wines of Hungary” campaign, a coordinated initiative designed to expand consumer awareness of Hungary’s historic wine regions and strengthen retail engagement across key markets. The program will begin rolling out in late 2025 and continue into 2026, marking the first nationwide educational and in-store activation series in the company’s history.
By Aqueous Spirits · Via GlobeNewswire · January 7, 2026
HII Hosts Secretary of The Navy and Top Naval Leaders at Ingalls Shipbuilding
PASCAGOULA, Miss., Jan. 07, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) hosted John Phelan, secretary of the Navy, along with Adm. Daryl Caudle, chief of naval operations, and Gen. Eric Smith, commandant of the Marine Corps, at its Ingalls Shipbuilding division Wednesday. The senior leaders toured the shipyard, gained insights into HII’s workforce initiatives and discussed Ingalls’ role in delivering the U.S. Navy’s “Golden Fleet” of advanced surface combatants.
By HII · Via GlobeNewswire · January 7, 2026
Bleichroeder Acquisition Corp. II Announces the Pricing of $250,000,000 Initial Public Offering
New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bleichroeder Acquisition Corp. II (the “Company”) announced today the pricing of its initial public offering of 25,000,000 units. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading tomorrow, January 8, 2026, under the ticker symbol “BBCQU.” Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BBCQ” and “BBCQW,” respectively. The offering is expected to close on January 9, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments, if any.
illumin Announces CFO Transition
TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM) (OTCQB: ILLMF) (“illumin” or the “Company”) today announced that Elliot Muchnik, Chief Financial Officer, is leaving the Company effective immediately to pursue other opportunities.
By illumin · Via GlobeNewswire · January 7, 2026
Clarios Accelerates Sodium-Ion Innovation with Strategic Partnership and Commitment to Serial Production
Investment in Altris, collaboration with InoBat, and roadmap to commercial production of sodium-ion batteries planned before the end of the decade.
By Clarios · Via GlobeNewswire · January 7, 2026
STACK Infrastructure Pursues Strategic Expansion Across Key U.S. Markets
Early-stage planning underway across multiple regions, including Louisiana
By STACK Infrastructure, Inc. · Via GlobeNewswire · January 7, 2026
OceanFirst Financial Corp. Schedules Earnings Conference Call
RED BANK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OceanFirst Financial Corp. (NASDAQ:OCFC), the holding company for OceanFirst Bank, today announced that it will issue its earnings release for the quarter ended December 31, 2025, on Thursday, January 22, 2026, after the market close. Management will then conduct a conference call at 11:00 a.m. Eastern Time, on Friday, January 23, 2026, to discuss highlights of the Company's quarterly operating performance.
By OceanFirst Financial Corp. · Via GlobeNewswire · January 7, 2026
Florida Drivers Face Two Paths as Lawmakers Near PIP Repeal Deadline
WEST PALM BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Connell Consulting Business Agency, LLC, as Florida lawmakers race toward final action on the Motor Vehicle Insurance (PIP) repeal bill, consumer advocates warn that the legislature is down to just 48 hours to fix a bill that could undo recent progress in lowering auto insurance premiums.
21shares Announces Distributions on TETH
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distribution for the 21shares Ethereum ETF (TETH) for staking rewards earned from its ETH holdings.
By 21Shares · Via GlobeNewswire · January 7, 2026
Klarna Group plc Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Klarna Group plc Class Action Lawsuit
SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Klarna Group plc (NYSE: KLAR) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Klarna's September 10, 2025, initial public offering ("IPO"). Klarna purports to be a “technology-driven payments company, with operations spanning multiple countries.”
By Robbins LLP · Via GlobeNewswire · January 7, 2026
DEFT Class Action Reminder: DeFi Technologies Inc. Shareholders With Large Losses Should Contact Robbins LLP for Information About Leading the Lawsuit Against DEFT
SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 7, 2026
Agilon Healthc, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Agilon Health, Inc. Class Action Lawsuit
SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."
By Robbins LLP · Via GlobeNewswire · January 7, 2026
FCX: Kirby McInerney LLP Advises Freeport-McMoran Inc. Investors of Class Action Lawsuit
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE:FCX) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · January 7, 2026
Buda Juice Announces Pricing of $20 Million Initial Public Offering
Shares Expected to Begin Trading on the NYSE American Exchange on January 8, 2026, under Ticker Symbol “BUDA”
By Buda Juice, Inc. · Via GlobeNewswire · January 7, 2026
F5 ALERT: Bragar Eagel & Squire, P.C. Reminds F5 Investors to Contact the Firm Before February 17th Regarding Their Rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In F5 (FFIV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 7, 2026
Quick Custom Intelligence Brings Live, Next-Gen AI to ICE Barcelona 2026 with Modulus
SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in AI-driven business intelligence for the gaming and hospitality industry, will showcase live demonstrations of its next-generation AI platform at ICE Barcelona 2026, taking place January 19–21 at the Fira Barcelona Gran Via. QCI will appear at a dedicated demo station within the Modulus booth (3X40), highlighting the continued strength of the companies’ strategic collaboration.
By QCI · Via GlobeNewswire · January 7, 2026
LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025
By LENZ Therapeutics, Inc. · Via GlobeNewswire · January 7, 2026
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026.
By Mesa Laboratories, Inc. · Via GlobeNewswire · January 7, 2026
Blüm Holdings Announces $3.05 Million Debt Conversion
DOWNEY, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company, today announced that on December 31, 2025 certain outstanding indebtedness of the Company, together with accrued interest, totaling approximately $3.05 million, was converted into shares of the Company’s common stock pursuant to a previously executed Debt Conversion Agreement.
By Blum Holdings · Via GlobeNewswire · January 7, 2026
SAVE THE DATE: NOVAGOLD 2025 Year-End Report, Conference Call and Video Webcast
VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) will release its 2025 year-end report before market open on January 22, 2026, followed by a conference call and video webcast to discuss the results at 8:00 am PT (9:00 am MT/11:00 am ET).
By NOVAGOLD RESOURCES INC. · Via GlobeNewswire · January 7, 2026
Applied Digital Reports Fiscal Second Quarter 2026 Results
DALLAS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, reported financial results for the fiscal second quarter ended November 30, 2025. The Company also provided operational updates.
By Applied Digital Corporation · Via GlobeNewswire · January 7, 2026
Celestica Q4 2025 Financial Results and Conference Call Thursday, January 29, 2026
TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Celestica Inc. (TSX and NYSE: CLS) will release its fourth quarter 2025 financial results after market close on Wednesday, January 28, 2026, and will host a conference call at 8:00am ET on Thursday, January 29, 2026.
By Celestica International LP · Via GlobeNewswire · January 7, 2026
Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) (the Company), a leading dental resource organization, announced the completion of two general dentistry practice acquisitions on December 31, 2025: Sunlight Dental in Phoenix, Ariz., and Weddell Dental in Bloomington, Minn. The addition of Sunlight Dental marks Park Dental Partners’ entry into its third state, expands the organization’s geographic reach, and strengthens its commitment to accessible, patient-centered care. Terms of the transactions were not disclosed.
By Park Dental Partners · Via GlobeNewswire · January 7, 2026
RODEOHOUSTON Takes Over New York City’s Times Square: Surprise Pop-Up Concert Reveals Russell Dickerson as Entertainer in 2026 Lineup
Full lineup to be revealed Thursday, Jan. 8
By Houston Livestock Show and Rodeo · Via GlobeNewswire · January 7, 2026
Michelin Launches Two New Ranges of Mountain Bike Tires for Enduro and E-Mountain Bikes
Michelin expands its Mountain Bike tire product portfolio with two new tire ranges for enduro enthusiasts. The Michelin Wild Enduro and E-Wild Performance Line tires are now available in the U.S. and Canada.
By MICHELIN · Via GlobeNewswire · January 7, 2026
Toll Brothers Announces Chairman and CEO Doug Yearley to Become Executive Chairman; Karl Mistry to Succeed Yearley as Chief Executive Officer
FORT WASHINGTON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, today announced that, as part of its long-term succession planning process, the Company’s Chairman and Chief Executive Officer Douglas C. Yearley, Jr. will be transitioning to the role of Executive Chairman of the Board on March 30, 2026. The Board of Directors has selected Karl K. Mistry, Executive Vice President and a 22-year Toll Brothers veteran, to succeed Mr. Yearley in the role of Chief Executive Officer and to join the Toll Brothers Board of Directors on March 30, 2026. As Executive Chairman, Mr. Yearley will continue to have a significant management role at the Company including guiding strategic initiatives and supporting the smooth transition of Mr. Mistry into the CEO role.
By Toll Brothers, Inc. · Via GlobeNewswire · January 7, 2026
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio
LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been chosen by Rigel Pharmaceuticals as limited distribution specialty pharmacy partner for TAVALISSE® (fostamatinib disodium hexahydrate), GAVRETO® (pralsetinib), and REZLIDHIA® (olutasidenib).
By Onco360 Oncology Pharmacy · Via GlobeNewswire · January 7, 2026
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 percent over the fourth quarter 2024 on an as-reported basis. Full year 2025 sales are expected to be approximately $2.936 billion, an increase of 16.5 percent over the prior year on an as-reported basis.
By Globus Medical · Via GlobeNewswire · January 7, 2026
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Wednesday, January 14, 2026. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.
By Sana Biotechnology, Inc · Via GlobeNewswire · January 7, 2026
FISERV ALERT: Bragar Eagel & Squire, P.C. is Investigating Fiserv, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fiserv (FISV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 7, 2026
INTEGER ALERT: Bragar Eagel & Squire, P.C. Reminds Stockholders that a Class Action Lawsuit Has Been Filed Against Integer Holdings Corporation and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Integer (ITGR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 7, 2026
Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and DeFi Technologies to Contact the Firm Before Upcoming Deadlines
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sprouts Farmers Market, Inc. (NASDAQ: SFM) and DeFi Technologies Inc. (NASDAQ: DEFT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · January 7, 2026
Grayscale Investments® Announces Rebalancing of Multi-Asset Funds for Fourth Quarter 2025
STAMFORD, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Grayscale Investments®, the world’s largest digital asset-focused investment platform*, and manager of Grayscale® Decentralized Finance (DeFi) Fund (OTCQB: DEFG) (DeFi Fund), Grayscale® Smart Contract Fund (GSC Fund), and Grayscale® Decentralized AI Fund (AI Fund), today announced the updated Fund Component weightings for each product in connection with their respective fourth quarter 2025 reviews.
By Grayscale Investments · Via GlobeNewswire · January 7, 2026
Costco Wholesale Corporation Reports December Sales Results
ISSAQUAH, Wash., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $29.86 billion for the retail month of December, the five weeks ended January 4, 2026, an increase of 8.5 percent from $27.52 billion last year.
By Costco Wholesale Corporation · Via GlobeNewswire · January 7, 2026
Live Oak Bancshares, Inc. Announces Date of Fourth Quarter 2025 Financial Results
WILMINGTON, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) today announced that it will report its fourth quarter 2025 financial results after U.S. financial markets close on Wednesday, January 21, 2026.
By Live Oak Bancshares, Inc. · Via GlobeNewswire · January 7, 2026
STUBHUB ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against StubHub Holdings, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In StubHub (STUB) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · January 7, 2026
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Varonis Systems
By Faruqi & Faruqi LLP · Via GlobeNewswire · January 7, 2026
LanzaTech Achieves Guaranteed Performance at Japan MSW-to-Ethanol Plant
Collaborative pilot at Kuji facility showcases robust ethanol yields using LanzaTech’s fermentation technology
By LanzaTech Inc. · Via GlobeNewswire · January 7, 2026
SAMstream Launches AI Platform to Help Organizations of All Sizes Find and Bid on Government Contracts
New end-to-end system combines opportunity discovery, real-time alerts, proposal drafting, and award-history insights; includes free SAMextension Chrome tool to guide SAM.gov registration
By SAMstream · Via GlobeNewswire · January 7, 2026
CMB.TECH FLEET UPDATE
Antwerp, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) has sold eight vessels, generating a capital gain of approximately 269.2 million USD in total.
By CMB.TECH · Via GlobeNewswire · January 7, 2026
Twelve Seas Investment Company III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 9, 2026
New York, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company III (Nasdaq: TWLVU) (the “Company”) announced today that, commencing January 9, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols “TWLV” and “TWLVR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “TWLVU.”
Abivax Provides 2026 Corporate Outlook
Abivax Provides 2026 Corporate Outlook
By Abivax · Via GlobeNewswire · January 7, 2026
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion
By Turn Therapeutics · Via GlobeNewswire · January 7, 2026
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026
By Terns Pharmaceuticals, Inc. · Via GlobeNewswire · January 7, 2026
Crane NXT to Participate in the CJS Securities 26th Annual New Ideas for the New Year Conference
WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the CJS Securities 26th Annual New Ideas for the New Year Conference on Wednesday, January 14, 2026 at 8:45 a.m. ET. 
By Crane NXT · Via GlobeNewswire · January 7, 2026
Terrestrial Energy to Participate in the 28th Annual Needham Growth Conference
CHARLOTTE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its Generation IV reactor technology, announced today that it will participate in the 28th Annual Needham Growth Conference on Tuesday, January 13, 2026, in New York, NY.
By Terrestrial Energy Inc. · Via GlobeNewswire · January 7, 2026
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. In addition, Phathom intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the total number of the securities offered in the public offering. There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering. 
By Phathom Pharmaceuticals · Via GlobeNewswire · January 7, 2026
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 11:15 a.m. PST.
By Annexon Biosciences · Via GlobeNewswire · January 7, 2026
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44thAnnual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific Time.
By RAPT Therapeutics, Inc. · Via GlobeNewswire · January 7, 2026
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference
NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT.
By Ultragenyx Pharmaceutical Inc. · Via GlobeNewswire · January 7, 2026
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference
FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Chief Financial Officer, Casey Heller, will present at the 28th Annual Needham Growth Conference.
By Definitive Healthcare Corp. · Via GlobeNewswire · January 7, 2026
Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results
ROCHESTER, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) --  Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its third quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Thursday, January 8, 2026 at 10:30 a.m. ET. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.
By Constellation Brands, Inc. · Via GlobeNewswire · January 7, 2026